medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2016, Number 2

<< Back Next >>

Rev Invest Clin 2016; 68 (2)

Aging Kidney Transplantation

Musso CG, Giordani MC, Imperiali N

Language: English
References: 38
Page: 68-74
PDF size: 80.65 Kb.


ABSTRACT

There are several immunological and non-immunological factors related to renal graft deterioration, and histological lesions such as interstitial fibrosis and tubular atrophy overlap with those observed in aging kidneys. Consequently, it has been proposed that kidney transplant senescence could contribute to graft loss. The process of cell senescence displays characteristics such as an increased expression of specific aging suppressor genes, shortened telomeres, mitochondrial changes, increased expression of negative regulators of the cell cycle, and immunological senescence. Additionally, tubular frailty characterizes the aged kidney, making it more susceptible to ischemia, reperfusion, toxic injury, and consequently, to inflammation. Moreover, renal tissue injury predisposes the older graft not only to progressive deterioration due to glomerular hyperfiltration, but also triggers acute rejection due to increased immunogenicity. In conclusion, renal graft senescence is a complex process, and its better understanding will help the nephrologist in its management in order to achieve a longer graft survival.


REFERENCES

  1. Li P, Tian C, Ge N, et al. Premature senescence of T cells in longterm survivors of renal transplantation. Biochem Biophys Res Commun. 2011;407:599-604.

  2. See comment in PubMed Commons belowTekin S, Yavuz HA, Yuksel Y, et al. Kidney transplantation from elderly donor. Transplant Proc. 2015;47:1309-11.

  3. Joosten SA, van Ham V, Nolan CE, et al. Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am J Pathol. 2003;162:1305-12.

  4. Heinbokel T, Hock K, Liu G, Edtinger K, Elkhal A, Tullius SG. Impact of immunosenescence on transplant outcome. Transpl Int. 2013;26:242-53.

  5. Musso CG. Geriatric nephrology and the ‘nephrogeriatric giants’. Int Urol Nephrol. 2002;34:255-6.

  6. Melk A, Schmidt BM, Braun H, et al. Effects of donor age and cell senescence on kidney allograft survival. Am J Transplant. 2009;9:114-23.

  7. Arvizu-Hernández M, Morales-Buenrostro LE, Vilatoba-Chapa M, et al. Time of occurrence of kidney acute antibody-mediated allograft rejection/acute cellular rejection and cell senescence: implications for function outcome. Transplant Proc. 2010;42:2486-92.

  8. Liu S, Lutz J, Antus B, et al. Recipient age and weight affect chronic renal allograft rejection in rats. J Am Soc Nephrol. 2001; 12:1742-9.

  9. de Fijter JW. The impact of age on rejection in kidney transplantation. Drugs Aging. 2005;22:433-49.

  10. Melk A, Schmidt BM, Vongwiwatana A, Rayner DC, Halloran PF. Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am J Transplant. 2005;5:1375-82.

  11. Yoon HE, Ghee JY, Piao S, et al. Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant. 2011;26:800-13.

  12. Sugiura H, Yoshida T, Mitobe M, et al. Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70. Nephrol Dial Transplant. 2010;25:60-8.

  13. Han DH, Piao SG, Song JH, et al. Effect of sirolimus on calcineurin inhibitor-induced nephrotoxicity using renal expression of KLOTHO, an antiaging gene. Transplantation. 2010;90:135-41.

  14. Tataranni T, Biondi G, Cariello M, et al. Rapamycin-induced hypophosphatemia and insulin resistance are associated with mTORC2 activation and Klotho expression. Am J Transplant. 2011;11:1656-64.

  15. Buemi M, Nostro L, Aloisi C, Cosentini V, Criseo M, Frisina N. Kidney aging: from phenotype to genetics. Rejuvenation Res. 2005;8:101-9.

  16. Sugiura H, Yoshida T, Tsuchiya K, et al. Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant. 2005;20:2636-45.

  17. Doma ski L, Kłoda K, Kwiatkowska E, et al. Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study. BMC Nephrol. 2015;16:23.

  18. Cagigi A, Rinaldi S, Santilli V, et al. Premature ageing of the immune system relates to increased anti-lymphocyte antibodies (ALA) after an immunization in HIV-1-infected and kidney-transplanted patients. Clin Exp Immunol. 2013;174:274-80.

  19. Sahin E, Colla S, Liesa M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011;470:359-65.

  20. Sugden MC, Caton PW, Holness MJ. PPAR control: It’s SIRTainly as easy as PGC. J Endocrinol. 2010;204:93-104.

  21. Herranz D, Muñoz-Martin M, Cañamero M, et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun. 2010;1:3.

  22. He W, Wang Y, Zhang MZ, et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest. 2010; 120:1056-68.

  23. Perico N, Remuzzi G, Benigni A. Aging and the kidney. Curr Opin Nephrol Hypertens. 2011;20:312-7.

  24. Cassis P, Conti S, Remuzzi G, Benigni A. Angiotensin receptors as determinants of life span. Pflugers Arch. 2010;459:325-32.

  25. Herbert KE, Mistry Y, Hastings R, Poolman T, Niklason L, Williams B. Angiotensin II-mediated oxidative DNA damage accelerates cellular senescence in cultured human vascular smooth muscle cells via telomere-dependent and independent pathways. Circ Res. 2008;102:201-8.

  26. Abadir PM, Foster DB, Crow M, et al. Identification and characterization of a functional mitochondrial angiotensin system. Proc Natl Acad Sci U S A. 2011;108:14849-54.

  27. Benigni A, Corna D, Zoja C, et al. Disruption of the Ang II type 1 receptor promotes longevity in mice. J Clin Invest. 2009; 119:524-30.

  28. Chkhotua AB, Abendroth D, Froeba G, Schelzig H. Up-regulation of cell cycle regulatory genes after renal ischemia/reperfusion: differential expression of p16(INK4a), p21(WAF1/CIP1) and p27(Kip1) cyclin-dependent kinase inhibitor genes depending on reperfusion time. Transpl Int. 2006;19:72-7.

  29. Furuzawa-Carballeda J, Lima G, Alberú J, et al. Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4α senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A. Clin Exp Immunol. 2012;167:330-7.

  30. Trzonkowski P, Debska-Slizie A, Jankowska M, et al. Immunosenescence increases the rate of acceptance of kidney allotransplants in elderly recipients through exhaustion of CD4+ T-cells. Mech Ageing Dev. 2010;131:96-104.

  31. McKay D, Jameson J. Kidney transplantation and the ageing immune system. Nat Rev Nephrol. 2012;8:700-8.

  32. Jiménez R, Carracedo J, Ramírez R, del Castillo D, Pérez R, Aljama AP. Acute renal rejection is associated with induction of replicative senescence in CD8+ T lymphocytes. Nefrologia. 2006;26:609-14.

  33. Meijers RW, Betjes MG, Baan CC, Litjens NH. T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance. World J Nephrol. 2014;3:268-76.

  34. Coppedè F. The epidemiology of premature aging and associated comorbidities. Clin Interv Aging. 2013;8:1023-32.

  35. Sinha JK, Ghosh S, Raghunath M. Progeria: a rare genetic premature ageing disorder. Indian J Med Res. 2014;139:667-74.

  36. Jennings P, Koppelstaetter C, Aydin S, et al. Cyclosporine A induces senescence in renal tubular epithelial cells. Am J Physiol Renal Physiol. 2007;293:F831-8.

  37. FNankivell BJ. Importance of age in evolving graft histology. Transplantation. 2007;83:682.

  38. Tullius SG, Milford E. Kidney allocation and the aging immune response. N Engl J Med. 2011;364:1369-70.




2020     |     www.medigraphic.com